5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine

5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Suppliers list
Company Name: T&W GROUP  
Tel: 021-61551611 13296011611
Email: contact@trustwe.com
Company Name: Zhengzhou GranLen pharmaceutical Technology Co., Ltd.  
Tel: 0371-85513397
Email: info@granlen.com
Company Name: Shandong utilizing biological technology co., LTD  
Tel: 18669728830 15966937598
Email: 3407650895@qq.com
Company Name: Zhengzhou Granlen Sciences, ltd.  
Tel: 0371-85513397 +86-18610099868
Email: info@granlen.com
Company Name: NewCan Biotech Limited  
Tel: +86-571-86912261 19975279805
Email: sales@newcanbio.com

5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine manufacturers

5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Basic information
Product Name:5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine
Synonyms:5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine;2,2'-Anhydro-5'-O-DMT-uridine;6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-, (2R,3R,3aS,9aR)-;2,2'-anhydro-5'-O-(4,4'-dimethoxytrityl)uridine;5’-O-(4,4’-Dimethoxytrityl)-2,2’-anhydro-D-uridine;5'-Protected 2,2'-anhydrouridine;5 ' - 0 - (4,4'-Dimethoxytri- tyl) - 2, 2'-an hydro- D-uridine;5'-Protected 2,2'-anhydrouridine
CAS:173170-12-2
MF:C30H28N2O7
MW:528.55
EINECS:
Product Categories:
Mol File:173170-12-2.mol
5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Structure
5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Chemical Properties
Melting point 129.5-130 °C
Boiling point 688.205±65.00 °C(Press: 760.00 Torr)(predicted)
density 1.356±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka12.509±0.40(predicted)
Safety Information
MSDS Information
5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Usage And Synthesis
Uses5'-Protected 2,2'-anhydrouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Preparation Products And Raw materials
Tag:5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine(173170-12-2) Related Product Information
5-CHLORO-2'-DEOXYURIDINE Uridine Capecitabine 6-Mercaptopurine Clofarabine Broxuridine